Detalhe da pesquisa
1.
Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer: A multicenter observational study.
Int J Urol
; 31(4): 342-347, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113343
2.
Pattern of expression of microRNA in patients with radiation induced bladder injury.
Oncology
; 2023 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38160665
3.
Predicting Objective Response of Pembrolizumab in Platinum-Refractory Urothelial Carcinoma Based on NLR Fluctuation and Liver Metastases.
Oncology
; 2023 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37839399
4.
Re-challenging chemotherapy after pembrolizumab in platinum-refractory urothelial carcinoma.
BJU Int
; 131(4): 477-485, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36098556
5.
Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinoma.
World J Urol
; 41(12): 3585-3591, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37924336
6.
Significance of second progression-free survival in patients with advanced urothelial cancer who received platinum-based combination chemotherapy followed by pembrolizumab.
Int J Urol
; 30(9): 730-736, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36575640
7.
Risk stratification for the prediction of overall survival could assist treatment decision-making at diagnosis of castration-resistant prostate cancer: a multicentre collaborative study in Japan.
BJU Int
; 127(2): 212-221, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32701219
8.
Prognostic model with alkaline phosphatase, lactate dehydrogenase and presence of Gleason pattern 5 for worse overall survival in low-risk metastatic hormone-sensitive prostate cancer.
Jpn J Clin Oncol
; 51(11): 1665-1671, 2021 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34296282
9.
Preoperative Measurement of the Modified Glasgow Prognostic Score Predicts Patient Survival in Non-Metastatic Renal Cell Carcinoma Prior to Nephrectomy.
Ann Surg Oncol
; 24(9): 2787-2793, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28643013
10.
Novel bladder preservation therapy with Osaka Medical College regimen.
J Urol
; 193(2): 443-50, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25167990
11.
Incidence of urethral stricture after bipolar transurethral resection of the prostate using TURis: results from a randomised trial.
BJU Int
; 115(4): 644-52, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24909399
12.
[Idiopathic Lumbar Hernia: A Case Report].
Hinyokika Kiyo
; 61(11): 449-53, 2015 Nov.
Artigo
em Japonês
| MEDLINE | ID: mdl-26699890
13.
Single session of high-intensity focused ultrasound for localized prostate cancer: treatment outcomes and potential effect as a primary therapy.
World J Urol
; 32(5): 1339-45, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24270943
14.
Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in Japan.
J Cancer Res Clin Oncol
; 150(4): 182, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38592548
15.
Prognostic Impact of Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab: A Multicenter Retrospective Study.
Clin Genitourin Cancer
; 22(1): 76-83, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37880020
16.
C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma.
Target Oncol
; 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38807017
17.
Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors.
Target Oncol
; 19(3): 401-410, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38546942
18.
Tissue Distribution of Cisplatin by Intra-arterial Infusion Route in Comparison to Systemic Route: Implication to Therapy for Node-positive Bladder Cancer.
In Vivo
; 37(1): 143-148, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36593015
19.
Optimal Time Point for Evaluation of Response to Pembrolizumab Treatment in Japanese Patients With Metastatic Urothelial Carcinoma.
Cancer Diagn Progn
; 3(3): 370-376, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37168961
20.
Concurrent palliative radiation with pembrolizumab for platinum-refractory urothelial carcinoma is associated with improved overall survival.
Clin Transl Radiat Oncol
; 39: 100558, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36545361